HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
MONDAY, April 1, 2019 (HealthDay News) -- Higher consumption of certain vitamins and carotenoids is associated with a significantly decreased risk for age-related cataract (ARC) in cohort studies, according to a meta-analysis published in the January issue of The American Journal of Clinical Nutrition.
Hong Jiang, from Xi'an Jiaotong University Health Science Center in China, and colleagues conducted a meta-analysis of randomized controlled trials (RCTs) and cohort studies published through June 2018 to assess dietary vitamin and carotenoid intake and ARC risk. The authors included eight RCTs and 12 cohort studies in the analysis.
The researchers found that most vitamins and carotenoids were significantly associated with a reduced risk for ARC in the cohort studies, including vitamin A (relative risk [RR], 0.81), vitamin C (RR, 0.8), vitamin E (RR, 0.9), β-carotene (RR, 0.9), and lutein or zeaxanthin (RR, 0.81). In RCTs, compared with placebo, vitamin E or β-carotene did not significantly reduce the risk for ARC. In cohort studies, the risk for ARC significantly decreased by 26 percent for every 10-mg/d increase in lutein or zeaxanthin intake, as well as by 18 percent for each 500-mg/d increase in vitamin C intake, by 8 percent for each 5-mg/d increase in β-carotene intake, and by 6 percent for every 5-mg/d increase in vitamin A intake.
"If we could delay the onset of ARC by 10 years, it could halve the number of people requiring surgery," a coauthor said in a statement.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 27, 2022